Cargando…
AZD-1222: New relapse of multiple sclerosis and neuromyelitis optica: 9 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008650/ http://dx.doi.org/10.1007/s40278-022-13241-9 |
Ejemplares similares
-
New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19
por: Fragoso, Yara D, et al.
Publicado: (2022) -
AZD-1222/elasomeran/tozinameran: Multiple sclerosis (MS) and relapse of MS: 16 case reports
Publicado: (2022) -
Azd-1222: Various toxicities: 9 case reports
Publicado: (2021) -
AZD-1222: Diffuse cutaneous systemic sclerosis: case report
Publicado: (2022) -
Azd-1222: Relapse of minimal change disease: 2 case reports
Publicado: (2021)